A meta-epidemiological study found lack of transparency and poor reporting of disproportionality analyses for signal detection in pharmacovigilance databases-Reference-Cited by-同舟云学术

A meta-epidemiological study found lack of transparency and poor reporting of disproportionality analyses for signal detection in pharmacovigilance databases

Published:2021-11 Issue: Volume:139 Page:191-198
ISSN:0895-4356
Container-title:Journal of Clinical Epidemiology
language:en
Short-container-title:Journal of Clinical Epidemiology

Author:

Khouri Charles,Revol Bruno,Lepelley Marion,Mouffak Amelle,Bernardeau Claire,Salvo Francesco,Pariente Antoine,Roustit Matthieu,Cracowski Jean-Luc

Funder

United Therapeutics Corporation

Publisher

Elsevier BV

Subject

Epidemiology

Reference45 articles.

1. Novel data mining methodologies for adverse drug event discovery and analysis;Harpaz;Clin Pharmacol Ther,2012

2. Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database: Commentary;Montastruc;Br J Clin Pharmacol,2011

3. Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: what a clinician should know on disproportionality analysis of spontaneous reporting systems;Raschi;Nutr Metab Cardiovasc Dis NMCD,2018

4. Lessons to be learnt from real-world studies on immune-related adverse events with checkpoint inhibitors: a clinical perspective from pharmacovigilance;Raschi;Target Oncol,2020

5. Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system;Harpaz;Clin Pharmacol Ther,2013

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Pharmacovigilance Florilegium;Clinical Therapeutics;2024-07

2. The evolving role of disproportionality analysis in pharmacovigilance;Expert Opinion on Drug Safety;2024-06-24

3. Moving the needle on proteasome inhibitor-induced pulmonary arterial hypertension: a definite maybe;European Respiratory Journal;2024-06

4. Not Just Another Reporting Guideline? Here’s Why READUS-PV is a Major Step Forward;Drug Safety;2024-05-08

5. The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration;Drug Safety;2024-05-07